BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24925688)

  • 1. Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.
    Duan WJ; Yu X; Huang XR; Yu JW; Lan HY
    Am J Pathol; 2014 Aug; 184(8):2275-84. PubMed ID: 24925688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.
    Liu Q; Mao H; Nie J; Chen W; Yang Q; Dong X; Yu X
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S88-95. PubMed ID: 18552272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
    Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
    J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
    Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
    Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
    Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A
    Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
    Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
    J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3-dependent and -independent pathways are involved in peritoneal membrane injury.
    Patel P; Sekiguchi Y; Oh KH; Patterson SE; Kolb MR; Margetts PJ
    Kidney Int; 2010 Feb; 77(4):319-28. PubMed ID: 19956083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of TGF-beta1 stimulation on the smad signal transduction pathway of human peritoneal mesothelial cells].
    Zhang H; Liu FY; Liu YH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):142-7. PubMed ID: 16145896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
    Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
    Shentu Y; Li Y; Xie S; Jiang H; Sun S; Lin R; Chen C; Bai Y; Zhang Y; Zheng C; Zhou Y
    Int Immunopharmacol; 2021 Apr; 93():107374. PubMed ID: 33517222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
    Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGS3 inhibits TGF-β1/Smad signalling in adventitial fibroblasts.
    Xu F; Liu Y; Shi L; Cai H; Liu W; Hu Y; Li Y; Yuan W
    Cell Biochem Funct; 2017 Aug; 35(6):334-338. PubMed ID: 28845525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.
    Liu KH; Zhou N; Zou Y; Yang YY; OuYang SX; Liang YM
    Med Sci Monit; 2019 Dec; 25():9346-9356. PubMed ID: 31812978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.
    Li Z; Zhang L; He W; Zhu C; Yang J; Sheng M
    Int J Mol Sci; 2014 Jul; 15(7):12959-71. PubMed ID: 25054320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions.
    Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A
    Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
    Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
    Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
    J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
    Brown KA; Pietenpol JA; Moses HL
    J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis.
    Lv ZD; Na D; Liu FN; Du ZM; Sun Z; Li Z; Ma XY; Wang ZN; Xu HM
    J Exp Clin Cancer Res; 2010 Oct; 29(1):139. PubMed ID: 21034459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.